The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin ... the Federal Trade Commission alleged in ...

CVS Health Corp. and UnitedHealth Group Inc. said members of the US Federal Trade Commission who voted to ... trade practices in how they managed insulin prescriptions. It said the companies ...